Selection and evaluation of probiotics

Handbook of Analysis of Active Compounds in Functional Foods

Volumn , Issue , 2012, Pages 607-637

  Martínez, Gaspar Pérez ^a   Bäuerl, Christine ^a   Carmen Collado Amores, M ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85055185344     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b11653     Document Type: Chapter

References (194)

1. Araya, M., Morelli, L., Reid, G., Sanders, M. E., Stanton, C., Pineiro, M., and Ben Embarek, P., Guidelines for the Evaluation of Probiotics in Food. pp. 1-11, Food and Agriculture Organization of the United Nations, World Health Organization: London, Ontario, Canada. 2002.
2. Office of Nutrition, Labeling, and Dietary Supplements in the Center for Food Safety and Applied Nutrition. Guidance for industry: Evidence-based review system for the scientific evaluation of health claims. U.S. Food and Drug Administration. 2009. Guidance Documents.
3. Food Quality and Standards Service. Report on Functional Foods. Food and Agriculture Organization of the United Nations (FAO). 2007.
4. Yamada, K., Sato-Mito, N., Nagata, J., and Umegaki, K., Health claim evidence requirements in Japan, The Journal of Nutrition, 138, 1192S, 2008.
5. Cummings, J. H., Antoine, J. M., Azpiroz, F., Bourdet-Sicard, R., Brandtzaeg, P., Calder, P. C., Gibson, G. R. et al., PASSCLAIM Gut health and immunity, European Journal of Nutrition, 43, ii118-ii173, 2004.
6. Yang, Y., Scientific substantiation of functional food health claims in China, The Journal of Nutrition, 138, 1199S, 2008.
7. Hasler, C. M., Health claims in the United States: An aid to the public or a source of confusion? The Journal of Nutrition, 138, 1216S, 2008.
8. Leuschner, R. G. K., Robinson, T. P., Hugas, M., Cocconcelli, P. S., Richard-Forget, F., Klein, G., Licht, T. R. et al., Qualified presumption of safety (QPS): A generic risk assessment approach for biological agents notified to the European Food Safety Authority (EFSA), Trends in Food Science & Technology, 21, 425, 2010.
9. Gomes, A. M., Pintado, M. E., and Malcata, F. X., Probiotics. In Nollet, L. M. L. and Toldra, F. (Eds.), Handbook of Dairy Food Analysis, CRC Press, Taylor & Francis Group: Boca Raton, FL, 2009, 503.
10. Perez-Martinez, G., Determination of glycolysis. In Nollet, L. M. L. and Toldra, F. (Eds.), Handbook of Dairy Food Analysis, CRC Press, Taylor & Francis Group: Boca Raton, FL, 2010, 385.
11. Gill, H. S. and Guarner, F., Probiotics and human health: A clinical perspective, Postgraduate Medical Journal, 80, 516, 2004.
12. Williams, N. T., Probiotics, American Journal of Health-System Pharmacy. 67, 449, 2010.
13. Lebeer, S., Vanderleyden, J., and De Keersmaecker, S. C. J., Genes and molecules of Lactobacilli supporting probiotic action, Microbiology and Molecular Biology Reviews, 72, 728, 2008.
14. Hörmannsperger, G. and Haller, D., Molecular crosstalk of probiotic bacteria with the intestinal immune system: Clinical relevance in the context of inflammatory bowel disease, International Journal of Medical Microbiology, 300, 63, 2010.
15. Haller, D., Antoine, J. M., Bengmark, S., Enck, P., Rijkers, G. T., and Lenoir-Wijnkoop, I., Guidance for substantiating the evidence for beneficial effects of probiotics: Probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome, Journal of Nutrition, 140, 690S, 2010.
16. Neish, A. S., Microbes in gastrointestinal health and disease, Gastroenterology, 136, 65, 2009.
17. Hooper, L. V. and Macpherson, A. J., Immune adaptations that maintain homeostasis with the intestinal microbiota, Nature Reviews Immunology, 10, 159, 2010.
18. Artis, D., Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut, Nature Reviews Immunology, 8, 411, 2008.
19. Backhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., and Gordon, J. I., The gut microbiota as an environmental factor that regulates fat storage, Proceedings of the National Academy of Sciences of the United States of America, 101, 15718, 2004.
20. Husebye, E., Hellstrom, P. M., and Midtvedt, T., Intestinal microflora stimulates myoelectric activity of rat small intestine by promoting cyclic initiation and aboral propagation of migrating myoelectric complex, Digestive Diseases and Sciences, 39, 946, 1994.
21. Stappenbeck, T. S., Hooper, L. V., and Gordon, J. I., Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells, Proceedings of the National Academy of Sciences of the United States of America, 99, 15451, 2002.
22. Sekirov, I., Tam, N. M., Jogova, M., Robertson, M. L., Li, Y., Lupp, C., and Finlay, B. B., Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection, Infection and Immunity, 76, 4726, 2008.
23. De Keersmaecker, S. C., Verhoeven, T. L., Desair, J., Marchal, K., Vanderleyden, J., and Nagy, I., Strong antimicrobial activity of L. rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid, FEMS Microbiology Letters, 259, 89, 2006.
24. Collado, M. C., Hernandez, M., and Sanz, Y., Production of bacteriocin-like inhibitory compounds by human fecal Bifidobacterium strains, Journal of Food Protection, 68, 1034, 2005.
25. Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., and Nelson, K. E., Metagenomic analysis of the human distal gut microbiome, Science, 312, 1355, 2006.
26. Savage, D. C., Microbial ecology of the gastrointestinal tract, Annual Review of Microbiology, 31, 107, 1977.
27. Dubos, R., Schaedler, R. W., Costello, R., and Hoet, P., Indigenous, normal, and autochthonous flora of the gastrointestinal tract, Journal of Experimental Medicine, 122, 67, 1965.
28. Frank, D. N., Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., and Pace, N. R., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases, Proceedings of the National Academy of Sciences of the United States of America, 104, 13780, 2007.
29. Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., and Relman, D. A., Diversity of the human intestinal microbial flora, Science, 308, 1635, 2005.
30. Ley, R. E., Lozupone, C. A., Hamady, M., Knight, R., and Gordon, J. I., Worlds within worlds: Evolution of the vertebrate gut microbiota, Nature Reviews Microbiology, 6, 776, 2008.
31. O’Hara, A. M. and Shanahan, F., The gut flora as a forgotten organ, EMBO Reports, 7, 688, 2006.
32. Zoetendal, E. G., von Wright, A., Vilpponen-Salmela, T., Ben-Amor, K., Akkermans, A. D. L., and de Vos, W. M., Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces, Applied and Environmental Microbiology, 68, 3401, 2002.
33. Hill, D. A., Hoffmann, C., Abt, M. C., Du, Y., Kobuley, D., Kirn, T. J., Bushman, F. D., and Artis, D., Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis, Mucosal Immunology, 3, 148, 2010.
34. Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R. et al., Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach, Gut, 55, 205, 2006.
35. Ley, R. E., Backhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., and Gordon, J. I., Obesity alters gut microbial ecology, Proceedings of the National Academy of Sciences of the United States of America, 102, 11070, 2005.
36. Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C. et al., Innate immunity and intestinal microbiota in the development of Type 1 diabetes, Nature, 455, 1109, 2008.
37. Hill, D. A. and Artis, D., Intestinal bacteria and the regulation of immune cell homeostasis, Annual Review of Immunology, 28, 623, 2010.
38. Turner, J. R., Intestinal mucosal barrier function in health and disease, Nature Reviews Immunology, 9, 799, 2009.
39. Murphy, K., Travers, P., and Walport, M., Janeway’s Immunobiology, Garland Science, Seventh Edition, Garland Science Textbooks, Taylor & Francis Group: Oxford and New York, 2007.
40. Kraus, T. A. and Mayer, L., Oral tolerance and inflammatory bowel disease, Current Opinion in Gastroenterology, 21, 692, 2005.
41. Hart, A. L., Lammers, K., Brigidi, P., Vitali, B., Rizzello, F., Gionchetti, P., Campieri, M., Kamm, M. A., Knight, S. C., and Stagg, A. J., Modulation of human dendritic cell phenotype and function by probiotic bacteria, Gut, 53, 1602, 2004.
42. Artis, D., Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut, Nature Reviews Immunology, 8, 411, 2008.
43. Jijon, H., Backer, J., Diaz, H., Yeung, H., Thiel, D., McKaigney, C., De, S. C., and Madsen, K., DNA from probiotic bacteria modulates murine and human epithelial and immune function, Gastroenterology, 126, 1358, 2004.
44. Nandakumar, N. S., Pugazhendhi, S., Madhu, M. K., Jayakanthan, K., and Ramakrishna, B. S., Effect of Vibrio cholerae on chemokine gene expression in HT29 cells and its modulation by Lactobacillus GG, Scandinavian Journal of Immunology, 69, 181, 2009.
45. Foligne, B., Nutten, S., Grangette, C., Dennin, V., Goudercourt, D., Poiret, S., Dewulf, J., Brassart, D., Mercenier, A., and Pot, B., Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria, The World Journal of Gastroenterology, 13, 236, 2007.
46. Lopez, P., Gueimonde, M., Margolles, A., and Suarez, A., Distinct Bifidobacterium strains drive different immune responses in vitro, The International Journal of Food Microbiology, 138, 157, 2010.
47. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermudez-Humaran, L. G., Gratadoux, J. J., Blugeon, S. et al., From the cover: Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients, Proceedings of the National Academy of Sciences of the United States of America, 105, 16731, 2008.
48. Strober, W., Zhang, F., Kitani, A., Fuss, I., and Fichtner-Feigl, S., Proinflammatory cytokines underlying the inflammation of Crohn’s disease, Current Opinion in Gastroenterology, 26, 310, 2010.
49. Schoenborn, J. R. and Wilson, C. B., Regulation of interferon-gamma during innate and adaptive immune responses, Advances in Immunology, 96, 41, 2007.
50. McGuirk, P., Higgins, S. C., and Mills, K. H., The role of regulatory T cells in respiratory infections and allergy and asthma, Current Allergy and Asthma Reports, 10, 21, 2010.
51. Latvala, S., Pietila, T. E., Veckman, V., Kekkonen, R. A., Tynkkynen, S., Korpela, R., and Julkunen, I., Potentially probiotic bacteria induce efficient maturation but differential cytokine production in human monocyte-derived dendritic cells, The World Journal of Gastroenterology, 14, 5570, 2008.
52. Kekkonen, R. A., Kajasto, E., Miettinen, M., Veckman, V., Korpela, R., and Julkunen, I., Probiotic Leuconostoc mesenteroides ssp. cremoris and Streptococcus thermophilus induce IL-12 and IFN-gamma production, The World Journal of Gastroenterology, 14, 1192, 2008.
53. Le, Y., Zhou, Y., Iribarren, P., and Wang, J., Chemokines and chemokine receptors: Their manifold roles in homeostasis and disease, Cellular and Molecular Immunology, 1, 95, 2004.
54. Warhurst, A. C., Hopkins, S. J., and Warhurst, G., Interferon gamma induces differential upregulation of alpha and beta chemokine secretion in colonic epithelial cell lines, Gut, 42, 208, 1998.
55. Preising, J., Philippe, D., Gleinser, M., Wei, H., Blum, S., Eikmanns, B. J., Niess, J. H., and Riedel, C. U., Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis, Applied and Environmental Microbiology, 76, 3048, 2010.
56. Ma, D. L., Forsythe, P., and Bienenstock, J., Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression, Infection and Immunity, 72, 5308, 2004.
57. Candela, M., Perna, F., Carnevali, P., Vitali, B., Ciati, R., Gionchetti, P., Rizzello, F., Campieri, M., and Brigidi, P., Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: Adhesion properties, competition against enteropathogens and modulation of IL-8 production, The International Journal of Food Microbiology, 125, 286, 2008.
58. Conway, P. L., Gorbach, S. L., and Goldin, B. R., Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells, Journal of Dairy Science, 70(1), 1-12, 1987.
59. Mishra, V. and Prasad, D. N., Application of in vitro methods for selection of Lactobacillus casei strains as potential probiotics, International Journal of Food Microbiology, 103, 109, 2005.
60. Linaje, R., Coloma, M. D., Perez-Martinez, G., and Zuniga, M., Characterization of faecal enterococci from rabbits for the selection of probiotic strains, Journal of Applied Microbiology, 96, 761, 2004.
61. Food and Drug Administration, Food substances affirmed as generally recognized as safe in feed and drinking water of animals; Hydrophobic silica, Daily Journal of the United States Government, 61, 43451, 1996.
62. EFSA, Introduction of a Qualified Presumption of Safety (QPS) approach for assessment of selected microorganisms referred to EFSA. Opinion of the Scientific Committee, EFSA Journal, 587, 1, 2007.
63. Huys, G., Vancanneyt, M., D’Haene, K., Vankerckhoven, V., Goossens, H., and Swings, J., Accuracy of species identity of commercial bacterial cultures intended for probiotic or nutritional use, Research in Microbiology, 157, 803, 2006.
64. Reid, G., The importance of guidelines in the development and application of probiotics, Current Pharmaceutical Design, 11, 11, 2005.
65. Gueimonde, M. and Salminen, S., New methods for selecting and evaluating probiotics, Digestive and Liver Disease, 38(Suppl 2), S242-S247, 2006.
66. Mohania, D., Nagpal, R., Kumar, M., Bhardwaj, A., Yadav, M., Jain, S., Marotta, F., Singh, V., Parkash, O., and Yadav, H., Molecular approaches for identification and characterization of lactic acid bacteria, Journal of Digestive Diseases, 9, 190, 2008.
67. Acedo-Félix, E. and Pérez-Martínez, G., Significant differences between Lactobacillus casei subsp. casei ATCC 393T and a commonly used plasmid-cured derivative revealed by a polyphasic study, International Journal of Systematic and Evolutionary Microbiology, 53, 67, 2003.
68. Lane, D. J., 16S/23S rRNA sequencing. In, Stackebrandt, E. and Goodfellow, M., (Eds.), Nucleic Acid Techniques in Bacterial Systematics, John Wiley & Sons Ltd.: New York, NY, 1991, 115.
69. Olasupo, N. A., Schillinger, U., and Holzapfel, W. H., Studies on some technological properties of predominant lactic acid bacteria isolated from Nigerian fermented foods, Food Biotechnology, 15, 157, 2001.
70. Bover-Cid, S., Hugas, M., Izquierdo-Pulido, M., and Vidal-Carou, M. C., Amino acid-decarboxylase activity of bacteria isolated from fermented pork sausages, International Journal of Food Microbiology, 66, 185, 2001.
71. Aymerich, T., Martin, B., Garriga, M., Vidal-Carou, M. C., Bover-Cid, S., and Hugas, M., Safety properties and molecular strain typing of lactic acid bacteria from slightly fermented sausages, Journal of Applied Microbiology, 100, 40, 2006.
72. Charteris, W. P., Kelly, P. M., Morelli, L., and Collins, J. K., Antibiotic susceptibility of potentially probiotic Lactobacillus species, Journal of Food Protection, 61, 1636, 1998.
73. Klare, I., Konstabel, C., Muller-Bertling, S., Reissbrodt, R., Huys, G., Vancanneyt, M., Swings, J., Goossens, H., and Witte, W., Evaluation of new broth media for microdilution antibiotic susceptibility testing of lactobacilli, pediococci, lactococci, and bifidobacteria, Applied and Environmental Microbiology, 71, 8982, 2005.
74. Mätto, J., van Hoek, A. H. A. M., Domig, K. J., Saarela, M., Florθz, A. B., Brockmann, E., Amtmann, E., Mayo, B., Aarts, H. J. M., and Danielsen, M., Susceptibility of human and probiotic Bifidobacterium spp. to selected antibiotics as determined by the Etest method, International Dairy Journal, 17, 1123, 2007.
75. Katla, A. K., Kruse, H., Johnsen, G., and Herikstad, H., Antimicrobial susceptibility of starter culture bacteria used in Norwegian dairy products, International Journal of Food Microbiology, 67, 147, 2001.
76. Corcoran, B. M., Stanton, C., Fitzgerald, G., and Ross, R. P., Life under stress: The probiotic stress response and how it may be manipulated, Current Pharmaceutical Design, 14, 1382, 2008.
77. Collado, M. C., Moreno, Y., Hernandez, E., Cobo, J. M., and Hernandez, M., Note. In vitro viability of Bifidobacterium strains isolated from commercial dairy products exposed to human gastrointestinal conditions, Food Science and Technology International, 11, 307, 2005.
78. Masco, L., Crockaert, C., Van, H. K., Swings, J., and Huys, G., In vitro assessment of the gastrointestinal transit tolerance of taxonomic reference strains from human origin and probiotic product isolates of Bifidobacterium, Journal of Dairy Science, 90, 3572, 2007.
79. Dunne, C., O’Mahony, L., Murphy, L., Thornton, G., Morrissey, D., O’Halloran, S., Feeney, M. et al., In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings, The American Journal of Clinical Nutrition, 73, 386S, 2001.
80. Ouwehand, A. C. and Salminen, S., In vitro adhesion assays for probiotics and their in vivo relevance: A review, Microbial Ecology in Health and Disease, 15, 175, 2003.
81. Kirjavainen, P. V., Ouwehand, A. C., Isolauri, E., and Salminen, S. J., The ability of probiotic bacteria to bind to human intestinal mucus, FEMS Microbiology Letters, 167, 185, 1998.
82. Aissi, E. A., Adhesion of some bifidobacterial strains to human enterocyte-like cells and binding to mucosal glycoproteins, Microbial Ecology in Health and Disease, 13, 32, 2001.
83. Collado, M. C., Gueimonde, M., Hernandez, M., Sanz, Y., and Salminen, S., Adhesion of selected Bifidobacterium strains to human intestinal mucus and the role of adhesion in enteropathogen exclusion, Journal of Food Protection, 68, 2672, 2005.
84. Laparra, J. M. and Sanz, Y., Comparison of in vitro models to study bacterial adhesion to the intestinal epithelium, Letters in Applied Microbiology, 49, 695, 2009.
85. Vesterlund, S., Paltta, J., Karp, M., and Ouwehand, A. C., Measurement of bacterial adhesion—In vitro evaluation of different methods, Journal of Microbiological Methods, 60, 225, 2005.
86. Muñoz-Provencio, D., Llopis, M., Antolin, M., de Torres, I., Guarner, F., Perez-Martinez, G., and Monedero, V., Adhesion properties of Lactobacillus casei strains to resected intestinal fragments and components of the extracellular matrix, Archives of Microbiology, 191, 153, 2009.
87. Chen, H. and Hoover, D. G., Bacteriocins and their food applications, Comprehensive Reviews in Food Science and Food Safety, 2, 82, 2003.
88. Cotter, P. D., Hill, C., and Ross, R. P., Bacteriocins: Developing innate immunity for food, Nature Reviews Microbiology, 3, 777, 2005.
89. Collado, M. C., Hernandez, M., and Sanz, Y., Production of bacteriocin-like inhibitory compounds by human fecal Bifidobacterium strains, The Journal of Food Protection, 68, 1034, 2005.
90. Avci, F. Y. and Kasper, D. L., How bacterial carbohydrates influence the adaptive immune system, Annual Review of Immunology, 28, 107, 2010.
91. Stingele, F., Neeser, J. R., and Mollet, B., Identification and characterization of the eps (exopolysaccharide) gene cluster from Streptococcus thermophilus Sfi6, The Journal of Bacteriology, 178, 1680, 1996.
92. Goh, K. K. T., Haisman, D. R., and Singh, H., Development of an improved procedure for isolation and purification of exopolysaccharides produced by Lactobacillus delbrueckii subsp. bulgaricus NCFB 2483, Applied Microbiology and Biotechnology, 67, 202, 2005.
93. Deguchi, Y., Morishita, T., and Mutai, M., Comparative studies on synthesis of water soluble vitamins among human species of bificobacteria, Agricultural and Biological Chemistry, 49, 13, 1985.
94. Pompei, A., Cordisco, L., Amaretti, A., Zanoni, S., Matteuzzi, D., and Rossi, M., Folate production by bifidobacteria as a potential probiotic property, Applied and Environmental Microbiology, 73, 179, 2007.
95. Camilo E., Zimmerman J., Mason, J. B., Golner, B., Russell, R., Selhub, J., and Rosenberg, I. H., Folate synthesized by bacteria in the human upper small intestine is assimilated by the host. Gastroenterology, 110(4), 991-998, 1996.
96. de Crecy-Lagard, V., El Yacoubi, B., de la Garza, R., Noiriel, A., and Hanson, A., Comparative genomics of bacterial and plant folate synthesis and salvage: Predictions and validations, BMC Genomics, 8, 245, 2007.
97. Santos, F., Vera, J. L., van der Heijden, R., Valdez, G., de Vos, W. M., Sesma, F., and Hugenholtz, J., The complete coenzyme B12 biosynthesis gene cluster of Lactobacillus reuteri CRL1098, Microbiology, 154, 81, 2008.
98. Difco Laboratories, Bacto folic acid assay medium, in Difco Manual, Becton Dickinson and Company, Sparks, MD, 2010, 234.
99. Begley, M., Hill, C., and Gahan, C. G. M., Bile salt hydrolase activity in probiotics, Applied and Environmental Microbiology, 72, 1729, 2006.
100. Begley, M., Hill, C., and Gahan, C. G. M., Bile salt hydrolase activity in probiotics, Applied and Environmental Microbiology, 72, 1729, 2006.
101. Moser, S. A. and Savage, D. C., Bile salt hydrolase activity and resistance to toxicity of conjugated bile salts are unrelated properties in lactobacilli, Applied and Environmental Microbiology, 67, 3476, 2001.
102. Corzo, G. and Gilliland, S. E., Measurement of bile salt hydrolase activity from Lactobacillus acidophilus based on disappearance of conjugated bile salts, Journal of Dairy Science, 82, 466, 1999.
103. Current Protocols in Immunology, John Wiley and Sons, Wiley On Line Library, 2009. Online ISBN: 9780471142737. http://onlinelibrary.wiley.com/book/10.1002/0471142735/toc
104. Vizoso Pinto, M. G., Schuster, T., Briviba, K., Watzl, B., Holzapfel, W. H., and Franz, C. M., Adhesive and chemokine stimulatory properties of potentially probiotic Lactobacillus strains, Journal of Food Protection, 70, 125, 2007.
105. Candela, M., Seibold, G., Vitali, B., Lachenmaier, S., Eikmanns, B. J., and Brigidi, P., Real-time PCR quantification of bacterial adhesion to Caco-2 cells: Competition between bifidobacteria and enteropathogens, Research in Microbiology, 156, 887, 2005.
106. Schmittgen, T. D. and Livak, K. J., Analyzing real-time PCR data by the comparative CT method, Nature Protocols, 3, 1101, 2008.
107. Canil, C., Rosenshine, I., Ruschkowski, S., Donnenberg, M. S., Kaper, J. B., and Finlay, B. B., Enteropathogenic Escherichia coli decreases the transepithelial electrical resistance of polarized epithelial monolayers, Infection and Immunity, 61, 2755, 1993.
108. Johnson-Henry, K. C., Donato, K. A., Shen-Tu, G., Gordanpour, M., and Sherman, P. M., Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function, Infection and Immunity, 76, 1340, 2008.
109. Seth, A., Yan, F., Polk, D. B., and Rao, R. K., Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC-and MAP kinase-dependent mechanism, Gastrointestinal and Liver Physiology, 294, G1060-G1069, 2008.
110. Zyrek, A. A., Cichon, C., Helms, S., Enders, C., Sonnenborn, U., and Schmidt, M. A., Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair, Cell Microbiology, 9, 804, 2007.
111. Ghadimi, D., Vrese, M., Heller, K. J., and Schrezenmeir, J., Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells, Inflammatory Bowel Diseases, 16, 410, 2010.
112. Ewaschuk, J. B., Diaz, H., Meddings, L., Diederichs, B., Dmytrash, A., Backer, J., Looijer-van, L. M., and Madsen, K. L., Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function, American Journal of Physiology: Gastrointestinal and Liver Physiology, 295, G1025-G1034, 2008.
113. Ewaschuk, J. B., Backer, J. L., Churchill, T. A., Obermeier, F., Krause, D. O., and Madsen, K. L., Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA, Infection and Immunity, 75, 2572, 2007.
114. Frick, J. S., Fink, K., Kahl, F., Niemiec, M. J., Quitadamo, M., Schenk, K., and Autenrieth, I. B., Identification of commensal bacterial strains that modulate Yersinia enterocolitica and dextran sodium sulfate-induced inflammatory responses: implications for the development of probiotics, Infection and Immunity, 75, 3490, 2007.
115. Cammarota, M., De, R. M., Stellavato, A., Lamberti, M., Marzaioli, I., and Giuliano, M., In vitro evaluation of Lactobacillus plantarum DSMZ 12028 as a probiotic: Emphasis on innate immunity, International Journal of Food Microbiology, 135, 90, 2009.
116. Vizoso Pinto, M. G., Rodriguez, G. M., Seifert, S., Watzl, B., Holzapfel, W. H., and Franz, C. M., Lactobacilli stimulate the innate immune response and modulate the TLR expression of HT29 intestinal epithelial cells in vitro, International Journal of Food Microbiology, 133, 86, 2009.
117. Johnson-Henry, K. C., Hagen, K. E., Gordonpour, M., Tompkins, T. A., and Sherman, P. M., Surface-layer protein extracts from Lactobacillus helveticus inhibit enterohaemorrhagic Escherichia coli O157:H7 adhesion to epithelial cells, Cell Microbiology, 9, 356, 2007.
118. Bergonzelli, G. E., Granato, D., Pridmore, R. D., Marvin-Guy, L. F., Donnicola, D., and Corthesy-Theulaz, I. E., GroEL of Lactobacillus johnsonii La1 (NCC 533) is cell surface associated: Potential role in interactions with the host and the gastric pathogen Helicobacter pylori, Infection and Immunity, 74, 425, 2006.
119. Yan, F. and Polk, D. B., Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells, The Journal of Biological Chemistry, 277, 50959, 2002.
120. Isono, A., Katsuno, T., Sato, T., Nakagawa, T., Kato, Y., Sato, N., Seo, G., Suzuki, Y., and Saito, Y., Clostridium butyricum TO-A culture supernatant downregulates TLR4 in human colonic epithelial cells, Digestive Diseases Sciences, 52, 2963, 2007.
121. Jan, G., Belzacq, A. S., Haouzi, D., Rouault, A., Metivier, D., Kroemer, G., and Brenner, C., Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria, Cell Death and Differentiation, 9, 179, 2002.
122. Kim, Y., Lee, D., Kim, D., Cho, J., Yang, J., Chung, M., Kim, K., and Ha, N., Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212, Archives of Pharmacal Research, 31, 468, 2008.
123. Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C. et al., Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors, Nature Medicine, 13, 35, 2007.
124. de Kivit, S., van Hoffen, E., Korthagen, N., Garssen, J., and Willemsen, L. E. M., Apical TLR ligation of intestinal epithelial cells drives a Th1-polarized regulatory or inflammatory type effector response in vitro, Immunobiology, 216, 518, 2011.
125. Dame, M. K., Bhagavathula, N., Mankey, C., Dasilva, M., Paruchuri, T., Aslam, M. N., and Varani, J., Human colon tissue in organ culture: Preservation of normal and neoplastic characteristics, In Vitro Cellular & Developmental Biology—Animal, 46, 114, 2010.
126. Resau, J. H., Sakamoto, K., Cottrell, J. R., Hudson, E. A., and Meltzer, S. J., Explant organ culture: A review, Cytotechnology, 7, 137, 1991.
127. Llopis, M., Antolin, M., Carol, M., Borruel, N., Casellas, F., Martinez, C., Espin-Basany, E., Guarner, F., and Malagelada, J. R., Lactobacillus casei downregulates commensals’ inflammatory signals in Crohn’s disease mucosa, Inflammatory Bowel Diseases, 14, 1, 2008.
128. Borruel, N., Casellas, F., Antolin, M., Llopis, M., Carol, M., Espiin, E., Naval, J., Guarner, F., and Malagelada, J. R., Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa, American Journal of Gastroenterology, 98, 865, 2003.
129. Council for Agricultural Science and Technology (CAST), Probiotics: Their potential to impact human health. CAST, Issue Paper 36, 2007.
130. Ruas-Madiedo, P., Gueimonde, M., de los Reyes-Gavilán, C. G., and Salminen, S., Short communication: Effect of exopolysaccharide isolated from “viili” on the adhesion of probiotics and pathogens to intestinal mucus. Journal of Dairy Science, 89(7), 2355-2358. 1-7-2006.
131. Alp, G., Aslim, B., Suludere, Z., and Akca, G., The role of hemagglutination and effect of exopolysaccharide production on bifidobacteria adhesion to Caco-2 cells in vitro, Microbiology and Immunology, 54, 658, 2010.
132. Sengul, N., Isik, S., Aslim, B., Ucar, G., and Demirbag, A. E., The effect of exopolysaccharide-producing probiotic strains on gut oxidative damage in experimental colitis, Digestive Diseases Sciences, 56, 707, 2011.
133. Sengul, N., Aslim, B., Ucar, G., Yucel, N., Isik, S., Bozkurt, H., Sakaogullari, Z., and Atalay, F., Effects of exopolysaccharide-producing probiotic strains on experimental colitis in rats, Diseases of the Colon & Rectum, 49, 250, 2006.
134. Tok, E. and Aslim, B., Cholesterol removal by some lactic acid bacteria that can be used as probiotic, Microbiology and Immunology, 54, 257, 2010.
135. Kim, Y., Oh, S., Yun, H. S., Oh, S., and Kim, S. H., Cell-bound exopolysaccharide from probiotic bacteria induces autophagic cell death of tumour cells, Letters in Applied Microbiology, 51, 123, 2010.
136. Kim, Y., Oh, S., and Kim, S. H., Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic Escherichia coli O157:H7, Biochemical and Biophysical Research Communications, 379, 324, 2009.
137. Kodali, V. P. and Sen, R., Antioxidant and free radical scavenging activities of an exopolysaccharide from a probiotic bacterium, Journal of Biotechnology, 3, 245, 2008.
138. Wu, M. H., Pan, T. M., Wu, Y. J., Chang, S. J., Chang, M. S., and Hu, C. Y., Exopolysaccharide activities from probiotic bifidobacterium: Immunomodulatory effects (on J774A.1 macrophages) and antimicrobial properties, International Journal of Food Microbiology, 144, 104, 2010.
139. Vinderola, G., Perdigon, G., Duarte, J., Farnworth, E., and Matar, C., Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity, Cytokine 36, 254, 2006.
140. Nakajima, H. A. J. I., Suzuki, Y. U. T. A., and Hirota, T. E. T. S., Cholesterol lowering activity of ropy fermented milk, Journal of Food Science, 57, 1327, 1992.
141. Kitazawa, H., Yamaguchi, T., and Itoh, T., B-cell mitogenic activity of slime products produced from slime-forming, encapsulated Lactococcus lactis ssp. cremoris, Journal of Dairy Science, 75, 2946, 1992.
142. Laparra, J. M. and Sanz, Y., Comparison of in vitro models to study bacterial adhesion to the intestinal epithelium, Letters in Applied Microbiology, 49, 695, 2009.
143. Gopal, P. K., Prasad, J., Smart, J., and Gill, H. S., In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli, International Journal of Food Microbiology, 67, 207, 2001.
144. Lim, S. M. and Im, D. S., Screening and characterization of probiotic lactic acid bacteria isolated from Korean fermented foods, Journal of Microbiology and Biotechnology, 19, 178, 2009.
145. Delgado, S., O’Sullivan, E., Fitzgerald, G., and Mayo, B., Subtractive screening for probiotic properties of lactobacillus species from the human gastrointestinal tract in the search for new probiotics, Journal of Food Science, 72, M310-M315, 2007.
146. Martin, R., Jimenez, E., Olivares, M., Marin, M. L., Fernandez, L., Xaus, J., and Rodriguez, J. M., Lactobacillus salivarius CECT 5713, a potential probiotic strain isolated from infant feces and breast milk of a mother-child pair, International Journal of Food Microbiology, 112, 35, 2006.
147. Nishida, S., Michinaka, A., Nakashima, K., Iino, H., and Fujii, T., Evaluation of the probiotic potential of Lactobacillus paracasei KW3110 based on in vitro tests and oral administration tests in healthy adults, The Journal of General and Applied Microbiology, 54, 267, 2008.
148. Candela, M., Perna, F., Carnevali, P., Vitali, B., Ciati, R., Gionchetti, R., Rizzello, F., Campieri, M., and Brigidi, P., Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: Adhesion properties, competition against enteropathogens and modulation of IL-8 production, International Journal of Food Microbiology, 125, 286, 2008.
149. Todorov, S. D., Botes, M., Guigas, C., Schillinger, U., Wiid, I., Wachsman, M. B., Holzapfel, W. H., and Dicks, L. M., Boza, a natural source of probiotic lactic acid bacteria, Journal of Applied Microbiology, 104, 465, 2008.
150. Mack, D. R., Ahrne, S., Hyde, L., Wei, S., and Hollingsworth, M. A., Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro, Gut, 52, 827, 2003.
151. Kim, Y., Kim, S. H., Whang, K. Y., Kim, Y. J., and Oh, S., Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells, Journal of Microbiology and Biotechnology, 18, 1278, 2008.
152. Horosova, K., Bujnakova, D., and Kmet, V., Effect of lactobacilli on E. coli adhesion to Caco-2 cells in vitro, Folia Microbiol (Praha)., 51, 281, 2006.
153. Preising, J., Philippe, D., Gleinser, M., Wei, H., Blum, S., Eikmanns, B. J., Niess, J. H., and Riedel, C. U., Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis, Applied and Environmental Microbiology, 76, 3048, 2010.
154. Imaoka, A., Shima, T., Kato, K., Mizuno, S., Uehara, T., Matsumoto, S., Setoyama, H., Hara, T., and Umesaki, Y., Anti-inflammatory activity of probiotic Bifidobacterium: Enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells, World Journal of Gastroenterology, 14, 2511, 2008.
155. Eun, C. S., Han, D. S., Lee, S. H., Jeon, Y. C., Sohn, J. H., Kim, Y. S., and Lee, J., Probiotics may reduce inflammation by enhancing peroxisome proliferator activated receptor gamma activation in HT-29 cells, Korean Journal of Gastroenterology, 49, 139, 2007.
156. Park, M. S., Kim, M. J., and Ji, G. E., Assessment of lipopolysaccharide-binding activity of Bifidobacterium and its relationship with cell surface hydrophobicity, autoaggregation, and inhibition of interleukin-8 production, Journal of Microbiology and Biotechnology, 17, 1120, 2007.
157. Riedel, C. U., Foata, F., Philippe, D., Adolfsson, O., Eikmanns, B. J., and Blum, S., Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation, World Journal of Gastroenterology, 12, 3729, 2006.
158. O’Hara, A. M., O’Regan, P., Fanning, A., O’Mahony, C., Macsharry, J., Lyons, A., Bienenstock, J., O’Mahony, L., and Shanahan, F., Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius, Immunology, 118, 202, 2006.
159. Chen, C. C., Chiu, C. H., Lin, T. Y., Shi, H. N., and Walker, W. A., Effect of probiotics Lactobacillus acidophilus on Citrobacter rodentium colitis: The role of dendritic cells, Pediatric Research, 65, 169, 2009.
160. de Moreno de, L. A., Dogi, C. A., Galdeano, C. M., Carmuega, E., Weill, R., and Perdigon, G., Effect of the administration of a fermented milk containing Lactobacillus casei DN-114001 on intestinal microbiota and gut associated immune cells of nursing mice and after weaning until immune maturity, BMC Immunology, 9, 27., 27, 2008.
161. Galdeano, C. M. and Perdigon, G., The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity, Clinical and Vaccine Immunology, 13, 219, 2006.
162. Dong, H., Rowland, I., Tuohy, K. M., Thomas, L. V., and Yaqoob, P., Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production, Clinical and Experimental Immunology, 161, 378, 2010.
163. Takeda, K., Suzuki, T., Shimada, S. I., Shida, K., Nanno, M., and Okumura, K., Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota, Clinical and Experimental Immunology, 146, 109, 2006.
164. Shida, K., Suzuki, T., Kiyoshima-Shibata, J., Shimada, S., and Nanno, M., Essential roles of monocytes in stimulating human peripheral blood mononuclear cells with Lactobacillus casei to produce cytokines and augment natural killer cell activity, Clinical and Vaccine Immunology, 13, 997, 2006.
165. Ogawa, T., Asai, Y., Tamai, R., Makimura, Y., Sakamoto, H., Hashikawa, S., and Yasuda, K., Natural killer cell activities of synbiotic Lactobacillus casei ssp. casei in conjunction with dextran, Clinical and Experimental Immunology, 143, 103, 2006.
166. Braat, H., de Jong, E. C., van den Brande, J. M., Kapsenberg, M. L., Peppelenbosch, M. P., van Tol, E. A., and van Deventer, S. J., Dichotomy between Lactobacillus rhamnosus and Klebsiella pneumoniae on dendritic cell phenotype and function, Journal of Molecular Medicine, 82, 197, 2004.
167. Peluso, I., Fina, D., Caruso, R., Stolfi, C., Caprioli, F., Fantini, M. C., Caspani, G. et al., Lactobacillus paracasei subsp. paracasei B21060 suppresses human T-cell proliferation, Infection and Immunity, 75, 1730, 2007.
168. Hoarau, C., Martin, L., Faugaret, D., Baron, C., Dauba, A., ubert-Jacquin, C., Velge-Roussel, F., and Lebranchu, Y., Supernatant from bifidobacterium differentially modulates transduction signaling pathways for biological functions of human dendritic cells, PLoS One, 3, e2753, 2008.
169. Fink, L. N., Zeuthen, L. H., Ferlazzo, G., and Frokiaer, H., Human antigen-presenting cells respond differently to gut-derived probiotic bacteria but mediate similar strain-dependent NK and T cell activation, FEMS Immunology and Medical Microbiology, 51, 535, 2007.
170. Hart, A. L., Lammers, K., Brigidi, P., Vitali, B., Rizzello, F., Gionchetti, P., Campieri, M., Kamm, M. A., Knight, S. C., and Stagg, A. J., Modulation of human dendritic cell phenotype and function by probiotic bacteria, Gut, 53, 1602, 2004.
171. Hua, M. C., Lin, T. Y., Lai, M. W., Kong, M. S., Chang, H. J., and Chen, C. C., Probiotic Bio-Three induces Th1 and anti-inflammatory effects in PBMC and dendritic cells, World Journal of Gastroenterology, 16, 3529, 2010.
172. Medina, M., Izquierdo, E., Ennahar, S., and Sanz, Y., Differential immunomodulatory properties of Bifidobacterium logum strains: Relevance to probiotic selection and clinical applications, Clinical and Experimental Immunology, 150, 531, 2007.
173. Vissers, Y. M., Snel, J., Zuurendonk, P. F., Smit, B. A., Wichers, H. J., and Savelkoul, H. F., Differential effects of Lactobacillus acidophilus and Lactobacillus plantarum strains on cytokine induction in human peripheral blood mononuclear cells, FEMS Immunology and Medical Microbiology, 59, 60, 2010.
174. Ibrahim, F., Ruvio, S., Granlund, L., Salminen, S., Viitanen, M., and Ouwehand, A. C., Probiotics and immunosenescence: Cheese as a carrier, FEMS Immunology and Medical Microbiology, 59, 53, 2010.
175. van, H. E., Korthagen, N. M., de, K. S., Schouten, B., Bardoel, B., Duivelshof, A., Knol, J., Garssen, J., and Willemsen, L. E., Exposure of intestinal epithelial cells to UV-killed Lactobacillus GG but not Bifidobacterium breve enhances the effector immune response in vitro, International Archives of Allergy and Immunology, 152, 159, 2010.
176. de Roock, S., van Elk, M., van Dijk, M. E., Timmerman, H. M., Rijkers, G. T., Prakken, B. J., Hoekstra, M. O., and de, K., I, Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans, Clinical and Experimental Allergy, 40, 103, 2010.
177. Flinterman, A. E., Knol, E. F., van Ieperen-van Dijk AG, Timmerman, H. M., Knulst, A. C., Bruijnzeel-Koomen, C. A., Pasmans, S. G., and van, H. E., Probiotics have a different immunomodulatory potential in vitro versus ex vivo upon oral administration in children with food allergy, International Archives of Allergy and Immunology, 143, 237, 2007.
178. Meyer, A. L., Micksche, M., Herbacek, I., and Elmadfa, I., Daily intake of probiotic as well as conventional yogurt has a stimulating effect on cellular immunity in young healthy women, Annals of Nutrition and Metabolism, 50, 282, 2006.
179. Niers, L. E., Timmerman, H. M., Rijkers, G. T., van Bleek, G. M., van Uden, N. O., Knol, E. F., Kapsenberg, M. L., Kimpen, J. L., and Hoekstra, M. O., Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines, Clinical and Experimental Allergy, 35, 1481, 2005.
180. Di Giacinto, C., Marinaro, M., Sanchez, M., Strober, W., and Boirivant, M., Probiotics ameliorate recurrent th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF β-bearing regulatory cells, The Journal of Immunology, 174, 3237, 2005.
181. Sturm, A., Rilling, K., Baumgart, D. C., Gargas, K., bou-Ghazale, T., Raupach, B., Eckert, J. et al., Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling, Infection and Immunity, 73, 1452, 2005.
182. Baba, N., Samson, S., Bourdet-Sicard, R., Rubio, M., and Sarfati, M., Selected commensal-related bacteria and Toll-like receptor 3 agonist combinatorial codes synergistically induce interleukin-12 production by dendritic cells to trigger a T helper type 1 polarizing programme, Immunology, 128, e523-e531, 2009.
183. Hvas, C. L., Kelsen, J., Agnholt, J., Hollsberg, P., Tvede, M., Moller, J. K., and Dahlerup, J. F., Crohn’s disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria, Scandinavian Journal of Gastroenterology, 42, 592, 2007.
184. Drakes, M., Blanchard, T., and Czinn, S., Bacterial probiotic modulation of dendritic cells, Infection and Immunity, 72, 3299, 2004.
185. Lopez, P., Gueimonde, M., Margolles, A., and Suarez, A., Distinct Bifidobacterium strains drive different immune responses in vitro, International Journal of Food Microbiology, 138, 157, 2010.
186. Carol, M., Borruel, N., Antolin, M., Llopis, M., Casellas, F., Guarner, F., and Malagelada, J. R., Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn’s disease, Journal of Leukocyte Biology, 79, 917, 2006.
187. Pathmakanthan, S., Li, C. K., Cowie, J., and Hawkey, C. J., Lactobacillus plantarum 299: Beneficial in vitro immunomodulation in cells extracted from inflamed human colon, Journal of Gastroenterology and Hepatology, 19, 166, 2004.
188. Smits, H. H., Engering, A., van der, K. D., de Jong, E. C., Schipper, K., van Capel, T. M., Zaat, B. A. et al., Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin, Journal of Allergy and Clinical Immunology, 115, 1260, 2005.
189. Thomas, S., Przesdzing, I., Metzke, D., Schmitz, J., Radbruch, A., and Baumgart, D. C., Saccharomyces boulardii inhibits lipopolysaccharide-induced activation of human dendritic cells and T cell proliferation, Clinical and Experimental Immunology, 156, 78, 2009.
190. Petrof, E. O., Claud, E. C., Sun, J., Abramova, T., Guo, Y., Waypa, T. S., He, S. M., Nakagawa, Y., and Chang, E. B., Bacteria-free solution derived from Lactobacillus plantarum inhibits multiple NF-kappaB pathways and inhibits proteasome function, Inflammatory Bowel Diseases, 15, 1537, 2009.
191. Niers, L. E., Hoekstra, M. O., Timmerman, H. M., van Uden, N. O., de Graaf, P. M., Smits, H. H., Kimpen, J. L., and Rijkers, G. T., Selection of probiotic bacteria for prevention of allergic diseases: Immunomodulation of neonatal dendritic cells, Clinical and Experimental Immunology, 149, 344, 2007.
192. Boyle, R. J., Mah, L. J., Chen, A., Kivivuori, S., Robins-Browne, R. M., and Tang, M. L., Effects of Lactobacillus GG treatment during pregnancy on the development of fetal antigen-specific immune responses, Clinical and Experimental Allergy, 38, 1882, 2008.
193. Ghadimi, D., Folster-Holst, R., de, V. M., Winkler, P., Heller, K. J., and Schrezenmeir, J., Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects, Immunobiology, 213, 677, 2008.
194. Rasche, C., Wolfram, C., Wahls, M., and Worm, M., Differential immunomodulating effects of inactivated probiotic bacteria on the allergic immune response, Acta Dermato-Venereologica, 87, 305, 2007.